ViaDerma, Inc. (VDRM)
OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
At close: Jul 16, 2026

ViaDerma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2017FY 2016FY 2015FY 2011FY 2010
Period EndingDec '17 Dec '17 Dec '16 Dec '15 Dec '11 Dec '10
Revenue
0.040.040.250.1919.0126.83
Revenue Growth
-99.75%-82.26%31.39%-98.99%-29.15%6.20%
Gross Profit
0.040.040.240.185.6610.15
Operating Income
-0.59-0.590.130.094.047.77
Net Income
-1.52-1.52-0.120.032.674.51
Earnings Per Share
-0.00-0.00-0.000.0019.4632.82
EPS Growth
----100.00%-40.70%11.25%

Cash & Debt

Fiscal YearCurrentFY 2017FY 2016FY 2015FY 2011FY 2010
Period EndingDec '17 Dec '17 Dec '16 Dec '15 Dec '11 Dec '10
Cash & Investments
0.010.010.0100.580.97
Total Debt
0.420.420.310.297.684.82
Net Cash (Debt)
-0.41-0.41-0.3-0.29-7.1-3.85
Net Cash Growth
------
Net Cash Per Share
-0.00-0.00-0.00-0.00-51.69-28.02

Cash Flow & CapEx

Fiscal YearTTMFY 2017FY 2016FY 2015FY 2011FY 2010
Period EndingDec '17 Dec '17 Dec '16 Dec '15 Dec '11 Dec '10
Operating Cash Flow
-0.17-0.17-0.01-0.016.057.78
Capital Expenditures
-----9.43-7.13
Free Cash Flow
-0.17-0.17-0.01-0.01-3.380.65
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2017FY 2016FY 2015FY 2011FY 2010
Period EndingDec '17 Dec '17 Dec '16 Dec '15 Dec '11 Dec '10
Gross Margin
84.20%84.20%95.74%91.66%29.79%37.82%
Operating Margin
-1327.78%-1327.78%50.58%48.88%21.25%28.95%
Pretax Margin
-3397.52%-3397.52%-48.34%14.14%18.66%24.23%
Profit Margin
-3397.52%-3397.52%-48.34%14.14%14.06%16.80%
FCF Margin
-374.49%-374.49%-4.79%-5.83%-17.77%2.43%

Valuation

Fiscal YearCurrentFY 2017FY 2016FY 2015FY 2011FY 2010
Period EndingJul '26 Dec '17 Dec '16 Dec '15 Dec '11 Dec '10
PE Ratio
---0.010.511.68
P/FCF Ratio
-----11.61
PS Ratio
11.04141.102.450.000.070.28